CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 165 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is 4.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $1,892,000 | -32.1% | 75,000 | -25.0% | 0.60% | -49.1% |
| Q1 2015 | $2,787,000 | +52.7% | 100,000 | 0.0% | 1.17% | +32.9% |
| Q4 2014 | $1,825,000 | -6.1% | 100,000 | -33.3% | 0.88% | -15.0% |
| Q3 2014 | $1,944,000 | -43.3% | 150,000 | -28.6% | 1.04% | -35.1% |
| Q2 2014 | $3,427,000 | -9.8% | 210,000 | -2.3% | 1.60% | -8.9% |
| Q1 2014 | $3,799,000 | -21.5% | 215,000 | +7.5% | 1.76% | -36.4% |
| Q4 2013 | $4,842,000 | – | 200,000 | – | 2.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,006 | $24,302,000 | 100.00% |
| TSP Capital Management Group, LLC | 886,398 | $3,138,000 | 1.60% |
| Marcus Capital, LLC | 109,950 | $389,000 | 0.42% |
| RTW INVESTMENTS, LP | 239,662 | $848,000 | 0.32% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 6,195,855 | $21,933,000 | 0.31% |
| Benchmark Capital Advisors | 66,800 | $236,000 | 0.20% |
| Bellevue Group AG | 160,000 | $566,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 632,944 | $2,241,000 | 0.09% |
| PDT Partners, LLC | 369,300 | $1,307,000 | 0.09% |
| Vident Investment Advisory, LLC | 196,715 | $696,000 | 0.08% |